The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
If you cannot find the publication or report you are seeking, please contact us at [email protected]. Thank you!
Refine your search by clicking filters to the left.
“Please, for the love of god, listen to the epidemiologists!” Dr. Chris McCabe, IHE CEO, provides an opinion piece along with UofA professor, Blake Murdoch, senior research associate with the Health Law Institute. The article highlights that understanding the exponential growth of infection is absolutely key to responding to and mitigating pandemics. The full article is available…
The Institute of Health Economics conducted an environmental scan to: describe available Alberta data assets to support the identification, surveillance, and management of high-risk patients with known cardiovascular disease; identify preliminary gaps in the available information; and formulate potential strategies to address the gaps identified. This environmental scan represents…
IHE CEO, Dr. Chris McCabe has been appointed to a multidisciplinary committee to plan the Third International Summit on Human Genome Editing, which will take place 7–9 March 2022 in London, UK. The committee, which includes representatives from eleven nations, is being chaired by Professor Robin Lovell-Badge FMedSci FRS. The three-day Summit will be held at The Francis Crick Institute…
Previous reports have examined predictors for inpatient stroke rehabilitation length of stay (LOS) and home discharge. However, none of them has provided a validation benchmark for predictability of identified risk factors. Accordingly, we examined temporal trends, geographic variations, and predicted inpatient rehabilitation LOS and home discharge for stroke patients in Alberta…
Global Health and Pharma Magazine (GHP) names the Institute of Health Economics – The Most Trusted Health and Economics Institute for 2021. The GHP awards program is in its sixth year and honors innovation and outstanding performance across the health related industries. The IHE is pleased to have received this recognition. A short article entitled “Creating Value through Collaboration”…
The Institute of Health Economics in partnership with Alberta Blue Cross has conducted an evaluation of Alberta Blue Cross’s digital wellness programs which are used by more than 360,000 plan members. The results demonstrate a positive health impact on health and savings in the health plans. The study found 81% of participants recorded improvements in health across a broad range…
IHE CEO Dr. Christopher McCabe presented on September 15th to the Pacific Northwest Economic Region (PNWER) COVID-19 Recovery Call webinar series on the One Society Network which he co-chairs with Dr. Christopher Cotton of Queen’s University.The presentation was titled: “One Society Network: Capturing Economic Impacts in Pandemic Policy”. At the beginning of the COVID-19 pandemic,…
IHE is a partner in a synthetic health data project sponsored by Health Cities in partnership with the University of Alberta School of Public Health, Merck Canada and Replica Analytics. The project advisory group includes Alberta Innovates and the Office of the Information and Privacy Commissioner of Alberta, The project was recently profiled in the University of Alberta Folio…
| Bing Guo, Carmen Moga, Charles Yan, Gareth Hopkin, Jeff Round, Jennifer Seida, Lisa Tjosvold, Michelle Pollock
This health evidence review assesses the clinical effectiveness and economic impact of various vascular risk reduction (VRR) initiatives that have been implemented in Alberta, and promising new initiatives, to inform priority-setting decisions regarding risk-reduction initiatives. The assessment also examines the clinical benefit that future projects would need to achieve for them…
| Susan Armijo-Olivo, Bing Guo, Nathan McClure, Carmen Moga, Negar Razavilar, Jeff Round, Lisa Tjosvold, Dat Tran, Charles Yan
This health evidence review assesses strategies for the delivery of high-quality and cost-effective stroke rehabilitation care in Alberta to inform decisions about how the province might increase care capacity for stroke rehabilitation services and maximize the benefits of effective treatment interventions. The review assesses two novel approaches to the delivery of high-quality…
IHE CEO, Dr. Chris McCabe, in his capacity as a health economics professor at the University of Alberta, participated in a study with colleagues from British Columbia: Dr. Caroline Colijn (SFU), Dr. Dean Karlen (UVic), Dr. Sarah Otto (UBC), Dr. Daniel Coombs (UBC), Dr. Eric Cytrynbaum (UBC), and Dr. Rob James (evidently.ca) which explores possible scenarios…
The Network of Alberta Health Economists (NOAHE.ca) in partnership with health economists from IHE, Alberta Health, and the Universities of Alberta and Calgary, is now accepting applications for the 2021 NOAHE Scholarship Awards. Check out: https://noahe.ca/about/awards-scholarships Deadline for application is September 19, 2021 with a start date of October 1, 2021 Qualifications…
IHE CEO, Dr. Chris McCabe provided a webinar presentation – “Demonstrating Value in Laboratory Medicine” on July 14th, 2021 as part of the international educational platform Labroots.Data and insights from laboratory tests help guide clinical decision-making, support policy changes, healthcare service planning and can have substantial…
| Ellen Rafferty, Laura Reifferscheid, Lawrence Svenson, Margaret Russell, Shannon Macdonald, Stephanie Booth
The impact of universal varicella vaccination on herpes zoster (HZ) risk in unvaccinated and vaccinated children, and its long-term influence on HZ epidemiology, remains unknown. This retrospective cohort study used population-based administrative health data for children born between 1993 and 2018. A universal varicella vaccination programme implementation corresponded to decreased…
Dr. Kate Harback, IHE Associate Director of Economics will be participating in a National Academy of Sciences workshop – “Aviation After a Year of Pandemic – Economics, People and Technology”. The workshop will examine what the future aviation industry will look like after a year of COVID-19? The virtual workshop will take place on June 28-30, 2021 from 12-4:30pm ET and focus…
| Erin Kirwin, Ellen Rafferty, Kate Harback, Jeff Round, Christopher McCabe
The objective of this study was to implement a model-based approach to identify the optimal allocation of a coronavirus disease 2019 (COVID-19) vaccine in the province of Alberta Canada. The results have three important policy implications: (i) optimal vaccine allocation will depend on the public health policies in place at the time of allocation and the impact of those policies…
The IHE is part of a research team funded by Alberta Innovates to investigate how widespread cannabis use is among arthritis patients. Self-medication and a lack of solid evidence to guide cannabis use for these purposes can lead to substantial harm. The research team will develop and validate a decision tool to help guide cannabis use to inform patients and health professionals.…
IHE Director of Economics Dr. Jeff Round participates in an interview with other colleagues for Global News about the pros and cons of using incentives to encourage members of the public to get vaccinated.Link: https://globalnews.ca/news/7902049/alberta-covid-19-vaccine-incentives/
Merck Canada Joins Synthetic Data Project Edmonton, AB, May 11, 2021 – Health City and the Institute of Health Economics (IHE) are pleased to welcome Merck Canada as a new partner to an innovative Alberta collaboration aimed at exploring the potential uses for synthetic health data. Merck Canada will be joining existing partners Alberta Innovates and the University of Alberta,…
IHE CEO leads national team to model full impact of pandemic restrictions Model to be used to predict unintended consequences, advise decision-makers during next public health crisis.April 14th, 2021 - While the COVID-19 pandemic continues its grip on Canada’s health-care system and economy,…
Be part of our growth! IHE is hiring for a variety of positions to support our growing program of work. There are a number of opportunities to work and/or train with the Institute of Health Economics (IHE). https://www.ihe.ca/about/careers-awards Senior Health Economist: The Institute of Health Economics is recruiting a Senior Health Economist to provide leadership on projects…
Location: On-site, hybrid, or remote in Canada Time Commitment: Full Time Salary: $100,000 to $130,000 subject to skills/experience Applications reviewed as received. About the role IHE is recruiting a Senior Principal Health Economist / Senior Principal Modeler to provide leadership on projects and in the development of our program of work. The successful candidates will contribute…
The COVID Strategic Choices Group is an interdisciplinary taskforce with experience across different domains of expertise (including epidemiology, public health, public policy, economics and business) and regions of Canada. IHE CEO, Dr. Christopher McCabe is a member of the COVID Strategic Choices Group. Members serve in their individual capacity and not as representatives of any…
This special supplement of Clinical Laboratory News showcases the winning teams from the UNIVANTS Healthcare Excellence Awards. It features innovative programs in Laboratory Medicine. The Institute of Health Economics is pleased to be one of the partners and judges in this prestigious program. Approximately 180 applications were initiated and three top-performing teams were selected…
The Institute for Health Economics (IHE) CEO co-authored an opinion editorial appearing in the Edmonton Journal with Timothy Caulfield, Dr. James Talbot and Dr. Noel Gibney. In it Dr. McCabe and fellow authors provide a critique of a previous editorial, appearing on February 8th, by Dr. Ari R. Joffe and Mr. David Redman. The concluding message of the editorial is: “Going forward,…
New report highlights importance of Stem Cell sector in Canada and opportunities for future competitiveness and contributions to economic recovery The Institute for Health Economics (IHE) has published a report which provides an overview of the current state and future prospects for stem cell/regenerative medicine in Canada. Specifically, it assesses the strengths, potential areas…
| Don Husereau, Jennifer Seida, Eddy Nason, John Sproule, Christopher McCabe
The purpose of this report is to provide a summary of current information and stakeholder perspectives regarding the current and future state of regenerative medicine (with a focus on stem cell-based research) in Canada and globally. Specifically, it assesses the strengths, potential areas for improvement, and opportunities for growth in the Canadian sector to ensure the future…
Little is currently known about the overall health service utilization and cost burden in patients with high risk for cardiovascular disease (HRCVD) who are recommended to start a statin to control dyslipidemia to prevent CVD events and mortality in short- and long-term care. We assessed the resource use and healthcare cost burden in this HRCVD patient population in Alberta, Canada,…
There are a number of opportunities to work and/or train with the Institute of Health Economics (IHE) to design and conduct model-based economic evaluations of emerging health care technologies. (see below). Health Economist / Mathematical modeler 12 Month Training Position(s): The IHE is recruiting up to two (2) candidates for a twelve (12) training position, with strong potential…
The Institute for Health Economics (IHE) conducted a roundtable on PF-ILD, in November 2021 and policy recommendations from the diverse stakeholder group provided some guidance on areas to focus on to improve the lives of those living with progressive fibrosing interstitial lung disease. Key actions identified at the roundtable included: increased surveillance for early identification…
A national roundtable provides direction for key components that should be included in national strategies to optimize care for patients with progressive fibrosing interstitial lung disease (PF-ILD). The Institute for Health Economics (IHE) conducted an invitational, virtual policy roundtable on progressive fibrosing interstitial lung disease (PF-ILD) on November 20th, 2020. This…
| Sherilyn Houle, Finlay McAlister, Cynthia Jackevicius, Anderson Chuck, Ross Tsuyuki
BACKGROUND: Pay-for-performance (P4P) is increasingly touted as a means to improve health care quality.
PURPOSE: To evaluate the effect of P4P remuneration targeting individual health careproviders.
Speaker Biographies Keynote Speaker Mr. Don DrummondFormer Senior Vice President and Chief Economist, TD Bank Financial Group Don Drummond is the former Senior Vice President and Chief Economist at TD Financial Group. He retired from TD to his current role as Matthews Fellow and Distinguished Visiting Scholar in the School of Policy Studies at Queens University. Prior to joining…
6 December 2012Edmonton, Alberta Introductory Remarks – Government of Alberta Honourable Fred Horne, Minister of Healthhttp://vimeo.com/channels/907291/56013748 Keynote Presentation Mr. Don Drummond, Former Senior Vice President and Chief Economist, TD Bank Financial Grouphttp://vimeo.com/channels/907291/56036522 Panel Discussion ModeratorDr. Annette Trimbee,…
6 December 2012 Edmonton, Alberta Value for Money in the Health System was the eighth in the series of Innovation Forums. The keynote speaker, Mr. Don Drummond, Matthews Fellow and Distinguished Visiting Scholar in the School of Policy Studies at Queens University, and a former Associate Deputy Minister of Finance in the Government of Canada, as well as a former Senior Vice President…
Value for Money in the Health System was the eighth in the series of Innovation Forums. The keynote speaker, Mr. Don Drummond, Matthews Fellow and Distinguished Visiting Scholar in the School of Policy Studies at Queens University, and a former Associate Deputy Minister of Finance in the Government of Canada, as well as a former Senior Vice President and Chief Economics at TD Financial…
Value for Money in the Health System was the eighth in the series of Innovation Forums. The keynote speaker, Mr. Don Drummond, Matthews Fellow and Distinguished Visiting Scholar in the School of Policy Studies at Queens University, and a former Associate Deputy Minister of Finance in the Government of Canada, as well as a former Senior Vice President and Chief Economics at TD Financial…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report performs an evaluation of the scientific evidence on the safety, performance, and effectiveness of universal and targeted preschool hearing screening (PHS) to inform the Infant and Preschool Screening Framework being developed by the Community and Public Health (CPH)…
Stroke Prevention and Management in Primary Care: a free forum at the 2012 Accelerating Primary Care Conference Sunday, 18 November 2012 Fairmont Banff Springs Hotel, Banff, Alberta Stroke Update 2012 was a free forum for primary care clinicians, held in conjunction with the annual Accelerating Primary Care conference in Banff, Alberta, November 18, 2012. The forum brought together…
Stroke Update 2012 was a free forum for primary care clinicians, held in conjunction with the annual Accelerating Primary Care conference in Banff, Alberta, November 18, 2012. The forum brought together 5 physician leaders to review the current “state of the art” in the rapidly advancing field of stroke prevention and care, with an emphasis on the role of primary care.…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This review focused on the best evidence available on the use of PSVS to detect vision conditions in asymptomatic preschool children (aged from birth to 6 years; not necessarily considered at risk for developing visual impairment) to determine the safety and efficacy/effectiveness…
The EQ-5D is a standardized instrument developed by the EuroQol group for use as a measure of health outcome. It considers five dimensions of health-related quality of life: mobility, self-care, usual activities, pain/discomfort, anxiety/depression. When the need for greater collaboration around implementation and use of the EQ-5D in Alberta was recognized in eary 2012, colleagues…
18 – 19 October 2012 Canmore, Alberta The EQ-5D is a standardized instrument developed by the EuroQol group for use as a measure of health outcome. It considers five dimensions of health-related quality of life: mobility, self-care, usual activities, pain/discomfort, anxiety/depression. When the need for greater collaboration around implementation and use of the EQ-5D in Alberta…
Biographies Stirling Bryan National Institute for Health and Clinical Excellence (NICE) Experience with Using the EQ-5D in Economic Analysis Dr. Stirling Bryan is a professor in UBC's School of Population & Public Health, and Director of the Centre for Clinical Epidemiology & Evaluation, Vancouver Coastal Health Research Institute. Dr. Bryan is an economist with a career-long specialization…
Thurs 18 Oct 2012 | Fri 19 Oct 2012 Thursday, 18 October 2012 08:45 – 09:00 Welcome and Opening Remarks Charlene McBrien-Morrison, Executive Director, Health Quality Council of Alberta Steve Buick, Director of Policy and Communications, Institute of Health Economics Kathryn Todd, Senior Vice President, Research, Alberta Health Services 09:00 – 09:30 EQ-5D - Building Common Understanding…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an update of a 2007 report. Permanent congenital hearing impairment/loss (PCHI/PCHL) is one of the most common congenital anomalies found at birth which can lead to delays and deficits in the development of speech, language, cognition, and learning, as well as…
This project is concerned with describing a comprehensive set of HTA products, not the methods used to produce them. The report describes various products produced by HTA agencies and provides a summary of the basic elements of these products, but an in-depth analysis of, or comparison between, the various products in terms of their methodology is beyond its scope. Information…
Background: The aim of this study was to extend an earlier retrospective cohort study of schizophrenia via a prospective study to a follow-up of 34 years, with an emphasis on describing the life-course of the illness.
| Thanh Nguyen, Anderson Chuck, Arto Ohinmaa, Philip Jacobs
Background: The benefits of pharmaceutical innovations are widely diffused; they accrue to the healthcare providers, patients, employers, and manufacturers. We estimate the societal monetary benefits of simvastatin in Canada and its distribution among different beneficiaries overtime.
| Mel Slomp, Philip Jacobs, Arto Ohinmaa, Roger Bland, Ray Block, Carolyn Dewa, Carina Wang
OBJECTIVES: In Canada, most mental health services are embedded in the publichealth care system. Little is known of the cost distribution within the mental healthpopulation. Our study aims to estimate the depression care costs of patients with adepression diagnosis, ranking them by the increasing total depression health carecosts.
| Logan McLeod, JoAnn Kingston-Riechers, Egon Jonsson
Abstract: The potential risks to patient safety in a primary care setting are different than the risks to patient safety in an acute care setting. The main differences arise from the organisational structures of primary care delivery and the greater involvement of patients in their care. To account for these differences, we present the Patient Safety in Primary Care Framework…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report provides an epidemiological profile of fetal aneuploidy and open neural tube defects (ONTD); describes the patterns of care, utilization trends, and factors affecting the provision of first and second trimester screening (FASTs) services for fetal aneuploidy and…
30 July 2012 Montréal, Québec The concept of “personalized medicine” in health is garnering increased attention. Personalized medicine can be defined as the tailoring of preventive, diagnostic, or therapeutic interventions to the characteristics of an individual or population. This may involve genetic or laboratory biomarker information. As personalized…
Monday, 30 July 2012Montréal, Québec Welcome, Introductions, and Overview John Sproule, IHEDon Husereau, University of Ottawa Roundtable Discussion – Assessment of System Readiness Moderator: John Sproule Is the current state of adoption and implementation ideal? What should the goals be for personalized medicine in Canada? What are the components of a vision…
This background document outlines the methods used to update the Alberta Clinical Practice Guideline (CPG) for the Evidence-Informed Primary Care Management of Low Back Pain, which was produced as part of the second phase of the Alberta Health Technology Assessment (HTA) Ambassador Program.
Link to Alberta Ambassador Guideline Adaptation Program
For which strategies of suicide prevention is there evidence of effectiveness? This report aims to synthesize research findings from existing systematic reviews to address two questions: What types of preventive interventions have been evaluated in the published literature? Which strategies have good-quality evidence to support them? Limited evidence - as well as variability by…
The concept of “personalized medicine” in health is garnering increased attention. Personalized medicine can be defined as the tailoring of preventive, diagnostic, or therapeutic interventions to the characteristics of an individual or population. This may involve genetic or laboratory biomarker information. As personalized medicine promises to increasingly change the…
Primary Care Management of Headache in Adults1st edition, July 2012Guideline Documents including Full Guideline (Hosted by Towards Optimized Practice (TOP) Alberta)
The guideline was developed as part of the Alberta Ambassador Guideline Adaptation Program (http://www.ihe.ca/research-programs/hta/aagap)
| Sherilyn Houle, Anderson Chuck, Finlay McAlister, Ross Tsuyuki
STUDY OBJECTIVE: To quantify the potential cost savings of a community pharmacy-basedhypertension management program based on the results of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN) study in terms of avoided cardiovascular events-myocardial infarction, stroke, and heart failure hospitalization, and to compare these cost savings…
31 May 2012 Edmonton, Alberta
Social Determinants of Health is the seventh IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
Key Forum Documents
Innovation Forum VII – Social Determinants of Health – FINAL PROGRAMDownload Final Program
Speaker Biographies Keynote Speaker Sir Michael MarmotDirector, Institute of Health Equity and MRC Research Professor in Epidemiology, University College London Sir Michael Marmot has led a research group on health inequalities for the past 30 years. He has been invited by the Regional Director of WHO Euro to conduct a European review of health inequalities. At the request of the…
31 May 2012Edmonton, Alberta Welcome and Introductions Dr. Lorne Tyrrell, Chair, Institute of Health EconomicsDownload Presentation http://vimeo.com/channels/907291/44105094 Dr. Chris Mazurkewich, Executive Vice President and CEO, Alberta Health Serviceshttp://vimeo.com/channels/907291/45175125 Honourable David Hancock, Minister of Human Serviceshttp://vimeo.com/channels/907291/44087423 …
PDF of a PowerPoint presentation by Sir Michael Marmot, Director, Institute of Health Equity and MRC Research Professor in Epidemiology, University College London.
IHE Innovation Forum VII – Social Determinants of Health
Social Determinants of Health is the seventh IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
| Bach Tran, Arto Ohinmaa, Anh Duong, Nhan Do, Long Nguyen, Quoc Nguyen, Steve Mills, Philip Jacobs, Stan Houston
PURPOSE: This longitudinal study assessed the changes in drug use patterns and health-related quality of life (HRQL) among HIV-positive drug users in the first methadonemaintenance treatment (MMT) cohort in Vietnam.
| Paula Corabian, Dagmara Chojecki, Christa Harstall
This exploratory report provides a summary of some of the published information on the current status of research in and potential future sphere of activity of nanomedicine (Part I) and an inventory of resources on nanotechnology and nanomedicine (Part II). Over the next 5 to 10 years it is expected that the overall impact of nanomedicine will be multifaceted, with significant…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report summarizes available key information on the use of bariatric treatments for adult obesity in Alberta and North America (mainly Canada). This analysis was intended to describe the profile of adult obesity (definition, progression, epidemiology, and population dynamics…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the research evidence on the safety and efficacy of insulin pump therapy, as compared to multiple daily insulin injections, in the treatment of children, adults, and pregnant women diagnosed with type 1 diabetes. The report also analyses the economic impact…
| Carmen Moga, Bing Guo, Don Schopflocher, Christa Harstall
This Methodology Paper summarizes the process, a modified Delphi approach, used to develop a specific checklist for the quality appraisal of case series studies. This work was supplemented with a review of other published checklists and an initial pilot test of the newly developed quality appraisal checklist. Researchers at the Institute of Health Economics with researchers from…
| Anne-Marie Boström, Susan E Slaughter, Dagmara Chojecki, Carole Estabrooks
OBJECTIVES: The recent emphasis on knowledge translation (KT) in health care is based on the premise that quality of care improves when research findings are translated into practice. This study aimed to identify the extent, nature, and settings of KT research pertaining to the care of older adults.
This report describes a framework for evaluating policies developed within the Alberta Health Technologies Decision Process (AHTDP) to strengthen the link between policy development and evidence. The framework was designed as a foundation upon which to build a more detailed and contextualized evaluative process in consultation with all stakeholders who are likely to be affected…
In February 2012, the Canadian Institute for Health Information (CIHI) in partnership with the Institute of Health Economics (IHE) sponsored a two day meeting of content, administrative and research experts to identify the breadth of diagnostic imaging studies that CIHI might feasibly undertake with its data or with data that could be easily obtained. The purpose of this report…
Sponsored by the Institute of Health Economics (IHE) – Methodology Forum Series. Presented at the Health Canada and Canadian Institutes of Health Research Personalised Medicine in Canada: A Multi-Stakeholder Workshop to Examine the Canadian Perspective, January 12, 2012. The specific objectives of this session/workshop were to: Explore issues relevant to economic evaluation…
| Bing Guo, Christa Harstall, Thomas Louie, Sander Veldhuyzen van Zanten, Levinus Dieleman
Aim: To critically appraise the clinical research evidence on the safety and effectiveness of FT compared with standard care in the treatment of patients with CDAD.
6 – 7 February 2012 Edmonton, Alberta As part of the Alberta Ambassador Guideline Adaptation Program, in February 2012, the Canadian Institute for Health Information (CIHI) in partnership with the Institute of Health Economics (IHE) sponsored a two day meeting of content, administrative and research experts to identify the breadth of diagnostic imaging studies that CIHI might feasibly…
From the Introduction: Until four or five decades ago, the clinical consensus about childhood depression was that it did not, and perhaps could not, occur (Lefkowitz & Burton, 1978; Rie, 1966; Rochlin, 1965; Wolfenstein, 1966). In fact, prior to 1960, childhood depression was rarely mentioned in the literature (Cytryn, 2003; Tisher, 2007). A number of studies and conceptualizations…
11 – 12 January 2012 Ottawa, Ontario The IHE has established a series of methodologic forums with the intent of identifying and addressing major methodological challenges in informing policies and decisions around the funding and use of health technologies, in partnership with its private and public stakeholders that are involved in the production of evidence and use of assessment.…
Speakers Dr. Jeffrey Hoch Associate Professor, Department of Health Policy, Management and Evaluation, University of Toronto; Director Pharmacoeconomics Research Unit, Cancer Care Ontario Dr. Stuart Peacock Associate Professor, School of Population and Public Health, University of British Columbia; Co-Director, Canadian Centre for Applied Research in Cancer Control Mr. Don Husereau…
Wednesday – Thursday, 11 – 12 January 2012Ottawa, Ontario Selected Plenary Presentations from Health Canada/CIHR Workshop Measuring Value in Personalized MedicineDr. Deborah Marshallhttp://player.vimeo.com/video/35735037 HTA Assessment in Australia - Challenges for Personalized MedicineDr. Robyn Wardhttp://player.vimeo.com/video/35785570 Stratified Medicine - Observations…
| Carissa Escober-Doran, Philip Jacobs, Carolyn Dewa
This study measures the return on investment for parent training at the pre- or early childhood stage. The purpose is to prevent conduct disorders in childhood, and mental health problems in adolescence and adulthood. The program studied is the Triple P program. The context is a one year birth cohort in Alberta. The costs are for a universal parental training program. The downstream…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #24. This report has been produced in response to a request from Alberta Health and Wellness for an update on the use of vagus nerve stimulation (VNS) for refractory epilepsy. The intent was to inform health policy makers, medical practitioners, and the public on the current status of the use of VNS for refractory…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #23. This report is a systematic review and critical appraisal of the literature on the use of formal outpatient diabetes education as a therapeutic tool for self-management in adult patients with type 2 diatetes. It has been prepared to provide information to the Capital Health Authority in Alberta, Canada and…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #1. This report has been prepared to provide information and assist discussion on the management of pressure sores, a significant source of morbidity in health care institutions. The focus of the report is on a specific technology, interface pressure measurement. It is expected that other issues in this are will…